EPS Corporation
EPS Corporation is a leading contract research organization (CRO) providing comprehensive solutions in drug and medical device development. Since its founding in 1991, EPS has grown by responding to changes in the development environment and market, expanding its services to include decentralized clinical trials (DCT), real-world data utilization, patient engagement support, digital health solutions, and health promotion services. The company aims to contribute to the healthcare industry by delivering innovative solutions and addressing social issues such as drug lag and loss, ensuring more patients have access to new treatments. EPS actively promotes virtual clinical trials (VCT) and has launched the "Virtual Go" initiative to support the digital transformation of clinical research, including online patient engagement, remote monitoring, and digital data collection systems like MiROHA developed by MICIN. EPS collaborates with MICIN to advance the adoption of virtual trials, leveraging their combined expertise in data science, digital health, and clinical trial management.
Industries
Nr. of Employees
Very Large (1000+)
Products
Real-world evidence analytics platform
Platform solution to generate clinical evidence from observational and real-world data sources for research and post-marketing use cases.
Patient engagement and interview service
Services to capture patient perspectives including interview-based inputs to inform development planning and patient-centered materials.
Decentralized clinical trial implementation program
Packaged offering for decentralized trial deployment covering design, digital tool integration, remote monitoring and operational logistics.
Cloud CSV reference documents
Downloadable materials describing computerized system validation practices and supplier assessment considerations for cloud environments used by regulated organizations.
Safety tracking and pharmacovigilance workflow software
Software-enabled solution for tracking safety case progress and supporting pharmacovigilance operations and reporting workflows.
One Stop Solution
A comprehensive outsourcing solution that brings together individual clinical research services to provide seamless communication and optimal quality completion.
Real-world evidence analytics platform
Platform solution to generate clinical evidence from observational and real-world data sources for research and post-marketing use cases.
Patient engagement and interview service
Services to capture patient perspectives including interview-based inputs to inform development planning and patient-centered materials.
Decentralized clinical trial implementation program
Packaged offering for decentralized trial deployment covering design, digital tool integration, remote monitoring and operational logistics.
Cloud CSV reference documents
Downloadable materials describing computerized system validation practices and supplier assessment considerations for cloud environments used by regulated organizations.
Safety tracking and pharmacovigilance workflow software
Software-enabled solution for tracking safety case progress and supporting pharmacovigilance operations and reporting workflows.
One Stop Solution
A comprehensive outsourcing solution that brings together individual clinical research services to provide seamless communication and optimal quality completion.
Services
Comprehensive support across clinical trial phases including planning, monitoring, data management, biostatistics and medical writing.
Design and operational services for decentralized trials including electronic consent, electronic outcome capture, remote monitoring, telemedicine and home-based trial logistics.
EDC/DDC operations, CDISC compliance reviews, integration with RTSM/IRT and electronic submission support.
Managed safety case processing, post-marketing surveillance program operation and safety signal management services.
Clinical evaluation, regulatory and operational support for medical device and in‑vitro diagnostic development programs.
CMC advisory services and regulatory interactions for drug substance and drug product activities.
Comprehensive support across clinical trial phases including planning, monitoring, data management, biostatistics and medical writing.
Design and operational services for decentralized trials including electronic consent, electronic outcome capture, remote monitoring, telemedicine and home-based trial logistics.
EDC/DDC operations, CDISC compliance reviews, integration with RTSM/IRT and electronic submission support.
Managed safety case processing, post-marketing surveillance program operation and safety signal management services.
Clinical evaluation, regulatory and operational support for medical device and in‑vitro diagnostic development programs.
CMC advisory services and regulatory interactions for drug substance and drug product activities.
Expertise Areas
- Clinical trial management
- Decentralized and hybrid clinical trials
- Clinical data management and eClinical integration
- Biostatistics and clinical analytics
Key Technologies
- Electronic consent (eConsent)
- Electronic patient-reported outcomes (ePRO/eCOA)
- Direct data capture / electronic data capture (DDC/EDC)
- Risk-based monitoring and central monitoring
News & Updates
EPS has established collaborations with patient support organizations to incorporate patient voices into development plans, launching new services.
EPS regularly conducts webinars on topics such as DCT, eConsent, and blockchain technology in clinical trials, promoting the adoption of innovative trial methods.
EPS and SUSMED demonstrated the use of blockchain technology to improve the reliability and efficiency of clinical trial data management.
EPS promotes the
EPS has been supporting the development of pharmaceuticals and medical devices since 1991, focusing on improving clinical trial efficiency and service quality.
EPS is committed to addressing social issues such as drug lag and loss, aiming to deliver new treatment options to more patients.
EPS has established collaborations with patient support organizations to incorporate patient voices into development plans, launching new services.
EPS regularly conducts webinars on topics such as DCT, eConsent, and blockchain technology in clinical trials, promoting the adoption of innovative trial methods.
EPS and SUSMED demonstrated the use of blockchain technology to improve the reliability and efficiency of clinical trial data management.
EPS promotes the
EPS has been supporting the development of pharmaceuticals and medical devices since 1991, focusing on improving clinical trial efficiency and service quality.
EPS is committed to addressing social issues such as drug lag and loss, aiming to deliver new treatment options to more patients.